UPPAL_HEALTHCARE_LIMITED - Accounts


Company Registration No. 08321724 (England and Wales)
UPPAL HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016
PAGES FOR FILING WITH REGISTRAR
UPPAL HEALTHCARE LIMITED
COMPANY INFORMATION
Director
Dr Manjinder Uppal
Company number
08321724
Registered office
Kingswood House
35 Orchehill Avenue
Gerrards Cross
Buckinghamshire
SL9 8QE
Accountants
Lentells Limited
17 - 18 Leach Road
Chard Business Park
Chard
Somerset
TA20 1FA
Business address
Kingswood House
35 Orchehill Avenue
Gerrards Cross
Buckinghamshire
SL9 8QE
UPPAL HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
UPPAL HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2016
31 December 2016
- 1 -
2016
2015
Notes
£
£
£
£
Fixed assets
Tangible assets
2
3,560
3,178
Current assets
Debtors
3
200
200
Cash at bank and in hand
587,448
445,378
587,648
445,578
Creditors: amounts falling due within one year
4
(34,641)
(29,696)
Net current assets
553,007
415,882
Total assets less current liabilities
556,567
419,060
Capital and reserves
Called up share capital
5
200
200
Profit and loss reserves
6
556,367
418,860
Total equity
556,567
419,060

The director of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2016 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.he director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 .he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and signed by the director and authorised for issue on 3 February 2017
Dr Manjinder Uppal
Director
Company Registration No. 08321724
UPPAL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016
- 2 -
1
Accounting policies
Company information

Uppal Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Kingswood House, 35 Orchehill Avenue, Gerrards Cross, Buckinghamshire, SL9 8QE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business , and is shown net of VAT and other sales related taxes . The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income., and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
33.33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

UPPAL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2016
1
Accounting policies
(Continued)
- 3 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax where applicable . where applicable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit. The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

The company operates an employee share ownership plan (ESOP) trust and has de facto control of the shares held by the trust and bears their benefits and risks. The company records assets and liabilities of the trust as its own. Consideration paid by the ESOP scheme for shares of the company is deducted from equity. Finance costs and administrative expenses incurred by the company in relation to the ESOP are recognised on an accruals basis.

UPPAL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2016
- 4 -
2
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2016
4,951
Additions
3,050
At 31 December 2016
8,001
Depreciation and impairment
At 1 January 2016
1,774
Depreciation charged in the year
2,667
At 31 December 2016
4,441
Carrying amount
At 31 December 2016
3,560
At 31 December 2015
3,178
3
Debtors
2016
2015
Amounts falling due within one year:
£
£
Other debtors
200
200
4
Creditors: amounts falling due within one year
2016
2015
£
£
Corporation tax
34,281
29,336
Other creditors
360
360
34,641
29,696
5
Called up share capital
2016
2015
£
£
Ordinary share capital
Issued and fully paid
75 A Ordinary of £1 each
75
75
25 B Ordinary of £1 each
25
25
50 C Ordinary of £1 each
50
50
50 D Ordinay of £1 each
50
50
200
200
UPPAL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2016
- 5 -
6
Profit and loss reserves
2016
2015
£
£
At the beginning of the year
418,860
298,586
Profit for the year
137,507
120,274
At the end of the year
556,367
418,860
2016-12-312016-01-01falseCCH SoftwareCCH Accounts Production 2016.300083217242016-01-012016-12-3108321724bus:Director12016-01-012016-12-3108321724bus:RegisteredOffice2016-01-012016-12-31083217242016-12-31083217242015-12-3108321724core:OtherPropertyPlantEquipment2016-12-3108321724core:OtherPropertyPlantEquipment2015-12-3108321724core:CurrentFinancialInstruments2016-12-3108321724core:CurrentFinancialInstruments2015-12-3108321724core:ShareCapital2016-12-3108321724core:ShareCapital2015-12-3108321724core:RetainedEarningsAccumulatedLosses2016-12-3108321724core:RetainedEarningsAccumulatedLosses2015-12-3108321724core:ComputerEquipment2016-01-012016-12-3108321724core:OtherPropertyPlantEquipment2015-12-3108321724core:OtherPropertyPlantEquipment2016-01-012016-12-3108321724core:LandBuildings2015-12-31083217242015-01-012015-12-3108321724bus:PrivateLimitedCompanyLtd2016-01-012016-12-3108321724bus:FRS1022016-01-012016-12-3108321724bus:OtherReportingRegime2016-01-012016-12-3108321724bus:FullAccounts2016-01-012016-12-31xbrli:purexbrli:sharesiso4217:GBP